Peter L J Wijngaard Selected Research

HDL Lipoproteins

4/2016

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter L J Wijngaard Research Topics

Disease

4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2016
1	Hypercholesterolemia 01/2023
1	Atherosclerosis 01/2021
1	Homozygous Familial Hypercholesterolemia 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Stable Angina 04/2016
1	Atherosclerotic Plaque (Atheroma) 01/2014

Drug/Important Bio-Agent (IBA)

6	LDL CholesterolIBA 01/2023 - 01/2019
5	ALN-PCSIBA 01/2023 - 01/2019
3	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2020
3	oxidized low density lipoproteinIBA 01/2023 - 01/2019
3	MDCO-216IBA 12/2016 - 01/2014
2	Proprotein Convertase 9IBA 01/2023 - 01/2020
2	Apolipoproteins AIBA 12/2016 - 01/2014
2	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2016 - 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	SodiumIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 12/2016
1	LipidsIBA 12/2016
1	HDL LipoproteinsIBA 04/2016
1	CholesterolIBA 04/2016
1	Apoprotein(a) (Apolipoprotein (a))IBA 04/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
2	Subcutaneous Injections 01/2021 - 01/2020